Price T Rowe Associates Inc Opti Nose, Inc. Transaction History

Price T Rowe Associates Inc

  • $869 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024
BUY
$1.17 - $1.94 $1,340 - $2,223
1,146 Added 6.55%
18,651 $28,000
Q4 2023

Feb 14, 2024
BUY
$1.02 - $1.47 $2,655 - $3,826
2,603 Added 17.47%
17,505 $23,000
Q3 2023

Nov 14, 2023
SELL
$0.93 - $1.38 $193,494 - $287,121
-208,059 Reduced 93.32%
14,902 $19,000
Q2 2023

Aug 14, 2023
BUY
$1.11 - $2.05 $247,486 - $457,070
222,961 New
222,961 $275,000

Others Institutions Holding OPTN

# of Institutions
62
Shares Held
88.3M
Call Options Held
0
Put Options Held
0
View Full List

About OptiNose, Inc.

OPTN Quotes by TradingView
  • Ticker OPTN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 83,277,504
  • Market Cap $45M
  • Description
  • OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists in the United States. The company offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically-acting cort...
More about OPTN
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email